126 results on '"Borer, Jeffrey S"'
Search Results
2. Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes
3. Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients
4. Resting Heart Rate in Cardiovascular Disease
5. Bioprosthesis Failure
6. Development of cardiovascular drugs: The U.S. regulatory milieu from the perspective of a participating nonregulator
7. Application of Transcatheter Repair to Tricuspid Regurgitation
8. Role of Payers in the Development of Cardiovascular Therapeutics
9. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement
10. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis
11. Cardiovascular drug development: is it dead or just hibernating?
12. Aortic Valve Surgery for Aortic Regurgitation
13. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles
14. Cardiovascular Drug Development
15. BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY
16. EFFICACY PROFILE OF IVABRADINE IN PATIENTS WITH HEART FAILURE PLUS ANGINA PECTORIS
17. Early Surgery or Watchful Waiting for Asymptomatic Severe Degenerative Mitral Regurgitation
18. WOMEN HAVE GREATER MID-TERM QUALITY OF LIFE BENEFIT THAN MEN AFTER VALVULAR SURGERY
19. PLASMA TRAIL AND OSTEOPROTEGERIN IN AR, AS AND STABLE CAD: RELATION TO CARDIAC GEOMETRY AND SYMPTOM STATUS
20. BIOMARKERS OF EXTRACELLULAR MATRIX IN LOW FLOW, LOW GRADIENT AORTIC STENOSIS: RELATIONSHIP TO HEMODYNAMIC, FUNCTIONAL, AND CLINICAL OUTCOMES - RESULTS FROM THE MULTICENTER TOPAS (TRULY OR PSEUDO SEVERE AORTIC STENOSIS) STUDY
21. VASODILATING DRUGS PROVIDE NO CLINICAL BENEFIT FOR PATIENTS WITH CHRONIC NONISCHEMIC MITRAL REGURGITATION
22. TRENDS IN RHEUMATIC VALVULAR HEART DISEASE: A LONGITUDINAL STUDY OF HOSPITALIZATIONS AND THE EFFECT OF IMMIGRATION IN NEW YORK CITY (1983-2007)
23. MYOCARDIAL MRNA CONCENTRATIONS FOR SECRETED BIOMARKERS IN AORTIC REGURGITATION VS AORTIC STENOSIS: CORRELATIONS WITH PLASMA PROTEIN CONCENTRATIONS AND LEFT VENTRICULAR DIMENSIONS
24. PREOPERATIVE EXERCISE CAPACITY BEST PREDICTS SURVIVAL AFTER SURGERY FOR CHRONIC NONISCHEMIC MITRAL REGURGITATION
25. Repair of the Congenitally Bicuspid Regurgitant Aortic Valve
26. Reply
27. The Clinical Development of Percutaneous Heart Valve Technology
28. Left ventricular hypertrophy in hypertrophic cardiomyopathy
29. Impact of systolic hypertension and impedance lowering drugs on clinical outcomes in chronic severe aortic regurgitation
30. Inhibition of the c-Jun N-terminal kinase pathway minimizes collagen remodeling in aortic regurgitant hearts
31. Survival after valve replacement for aortic regurgitation: Prediction from noninvasive contractility measurement and comparison with census-expected survival
32. Autocrine-paracrine factors released by cardiac fibroblasts stimulate abnormal myocardial fibronectin synthesis in aortic regurgitation
33. Increased fibronectin synthesis is stimulated by autocrine factors secreted by fibroblasts from aortic regurgitant hearts
34. Trends in rheumatic valvular heart disease: a longitudinal study of hospitalizations in New York state (1983–1999)
35. Pathological fibrosis in aortic regurgitation is mediated by c-Jun/ATF-2 complex formation with camp response element in cardiac fibroblasts
36. A load adjusted performance index enhances prediction of temporal changes in left ventricular ejection fraction among asymptomatic patients with chronic nonischemic aortic regurgitation and initially normal resting function
37. Impact of vasodilator use on adverse events in chronic severe aortic regurgitation
38. 910-16 Ventricular Size and Function Early and Late After Mitral Valve Repair vs Mitral Valve Replacement for Mitral Regurgitation
39. 747-6 Myocardial Blood Flow in Aortic Regurgitation: Comparison of Global and Regional Blood Flow to Regional Wall Stresses
40. 978-61 Prognostic Value of Radionuclide Cineangiography for Determining Benefit of Bypass Grafting in 3-Vessel Coronary Artery Disease
41. 901-102 Atherosclerotic Plaques Imaged by Tc-99m-Labeled Synthetic Peptide
42. 975-81 Prognostic Value of Ultra-Low Frequency Heart Rate Variability in Chronic Aortic Regurgitation
43. Electrocardiographic diagnosis of left ventricular hypertrophy by the time-voltage integral of the QRS complex
44. Histologic evolution of heart failure in chronic experimental aortic regurgitation
45. Relative Insensitivity of densitometric stenosis measurement to lumen edge determination
46. Natural history of asymptomatic severe mitral regurgitation: Dissociation of symptom development and ventricular performance?
47. The Clinical Development of Percutaneous Heart Valve Technology A Position Statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA)
48. Development of cardiovascular drugs The U.S. regulatory milieu from the perspective of a participating nonregulator
49. Geometric and functional correlates of electrocardiographic repolarization and voltage abnormalities in aortic regurgitation
50. Task force III: Major demographic and epidemiologic trends affecting adult cardiology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.